Hypersecretion of luteinizing hormone and the polycystic ovary syndrome
- PMID: 8276945
- DOI: 10.1093/humrep/8.suppl_2.123
Hypersecretion of luteinizing hormone and the polycystic ovary syndrome
Abstract
Hypersecretion of luteinizing hormone (LH) is a significant cause of infertility and miscarriage in women with the polycystic ovary syndrome. Many theories have been suggested for the aetiology of pituitary oversecretion of LH. These include increased pulsatility of gonadotrophin releasing hormone (GnRH) hypothalamic dysfunction, altered pituitary sensitivity to GnRH, hyperinsulinaemic stimulation of the pituitary gland and perturbed ovarian-pituitary feedback of steroid hormones. None of these hypotheses fully explain the phenomenon of LH hypersecretion and there has been much debate in the literature on this subject. This paper reviews some of the important clinical studies that have examined the evolving story of hypersecretion of LH and presents in-vivo and in-vitro evidence that suggests that disordered ovarian-pituitary feedback is central to the problem, possibly through a perturbed secretion of nonsteroidal ovarian hormones.
Similar articles
-
Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions.J Clin Endocrinol Metab. 2006 Apr;91(4):1309-16. doi: 10.1210/jc.2005-2099. Epub 2006 Jan 24. J Clin Endocrinol Metab. 2006. PMID: 16434454
-
Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome.J Endocrinol Invest. 1998 Oct;21(9):602-11. doi: 10.1007/BF03350785. J Endocrinol Invest. 1998. PMID: 9856414 Review.
-
Ovarian control of pituitary sensitivity of luteinizing hormone secretion to gonadotropin-releasing hormone in women with the polycystic ovary syndrome.Fertil Steril. 2009 Oct;92(4):1378-1380. doi: 10.1016/j.fertnstert.2009.04.033. Epub 2009 May 24. Fertil Steril. 2009. PMID: 19467538 Clinical Trial.
-
Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment.Hum Reprod. 1997 Jun;12(6):1156-64. doi: 10.1093/humrep/12.6.1156. Hum Reprod. 1997. PMID: 9221993
-
Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome.Arch Med Res. 2001 Nov-Dec;32(6):544-52. doi: 10.1016/s0188-4409(01)00325-3. Arch Med Res. 2001. PMID: 11750729 Review.
Cited by
-
Comparison between Unilateral and Bilateral Ovarian Drilling in Clomiphene Citrate Resistance Polycystic Ovary Syndrome Patients: A Randomized Clinical Trial of Efficacy.Int J Fertil Steril. 2015 Apr-Jun;9(1):9-16. doi: 10.22074/ijfs.2015.4202. Epub 2015 Apr 21. Int J Fertil Steril. 2015. PMID: 25918587 Free PMC article.
-
Influence of KISS1 gene polymorphisms on the risk of polycystic ovary syndrome and its associated variables, in Saudi women.BMC Endocr Disord. 2020 May 7;20(1):59. doi: 10.1186/s12902-020-0537-2. BMC Endocr Disord. 2020. PMID: 32380991 Free PMC article.
-
Ovulation induction techniques in women with polycystic ovary syndrome.Front Med (Lausanne). 2022 Aug 12;9:982230. doi: 10.3389/fmed.2022.982230. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36035398 Free PMC article. Review.
-
Effect Modification of LHCGR Gene Variant (rs2293275) on Clinico-Biochemical Profile, and Levels of Luteinizing Hormone in Polycystic Ovary Syndrome Patients.Biochem Genet. 2023 Aug;61(4):1418-1432. doi: 10.1007/s10528-022-10327-z. Epub 2023 Jan 12. Biochem Genet. 2023. PMID: 36633772
-
The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma.PPAR Res. 2007;2007:49109. doi: 10.1155/2007/49109. PPAR Res. 2007. PMID: 17389770 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical